For citations:
Mulyukova D.M., Sakaeva D.D. What do we know about neurotoxicity? Supportive Therapy in Oncology. 2025;2(1):13-20. (In Russ.) https://doi.org/10.17650/3034-2473-2025-2-1-13-20
Fullscreen
Popular articles
Vol 1, No 1 (2024)
Vol 1, No 2 (2024)
Vol 1, No 1 (2024)
Editor-in-Chief
Orlova Rashida V.
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Authors
Keywords
adverse event
antitumor drug therapy
artificial nutrition
brain metastases
breast cancer
children
dose-dense neoadjuvant chemotherapy
granulocyte colony-stimulating factor
hereditary disease
malignant neoplasm
metastatic renal cell carcinoma
neurofibromatosis type 1
neurotoxicity
plexiform neurofibroma
sarcopenia
sarcopenic obesity
standard neoadjuvant chemotherapy
systemic therapy
targeted therapy
toxicity
tumor
115478, Moscow, Kashirskoye Shosse, 24, bldg.15, Research Institute of Carcinogenesis, 3rd floor.
Mailing Address: ABV-Press Publishing House, PO box 136, Moscow 115522, Russia.
Post address: 115522, Moscow, p/o box 136, “ABV-press” publishing house”, LLC.
Tel./fax: +7 (499) 929-96-19
Web-site: www.abvpress.ru
E-mail: a.donskih@abvpress.ru
